MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
31.43
-0.81
-2.51%
Pre Market: 31.45 +0.02 +0.05% 06:26 08/13 EDT
OPEN
32.43
PREV CLOSE
32.24
HIGH
33.00
LOW
31.25
VOLUME
79
TURNOVER
0
52 WEEK HIGH
44.28
52 WEEK LOW
17.72
MARKET CAP
960.17M
P/E (TTM)
-48.3241
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSTL last week (0803-0807)?
Weekly Report · 3d ago
Castle Biosciences Ups 2026 Outlook Amid Growth
TipRanks · 3d ago
Castle Biosciences (CSTL) Q2 2026 Earnings Call Transcript
NASDAQ · 5d ago
Castle Biosciences price target raised to $44 from $40 at BTIG
TipRanks · 08/04 11:06
Castle Biosciences Reaffirmed at Buy as Strong Q2 and Raised 2026 Outlook Support 43% Upside to Unchanged $40 Price Target
TipRanks · 08/03 11:45
Castle Biosciences Price Target Raised to $44.00/Share From $40.00 by BTIG
Dow Jones · 08/03 10:45
Castle Biosciences Is Maintained at Buy by BTIG
Dow Jones · 08/03 10:45
BTIG Maintains Buy on Castle Biosciences, Raises Price Target to $44
Benzinga · 08/03 10:35
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers around six commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology ophthalmology and includes a test to guide systemic treatment decisions in patients with moderate-to-severe AD. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for patients with cutaneous squamous cell carcinoma (SCC).

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.